AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Aquestive Therapeutics, Inc. Director's Dealing 2024

Apr 26, 2024

32552_dirs_2024-04-26_b6f4d05f-e726-4bc0-a7fd-f8849a4dd53c.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Aquestive Therapeutics, Inc. (AQST)
CIK: 0001398733
Period of Report: 2024-04-01

Reporting Person: Jenkins Abigail L. (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct